Israel vs Türkiye: Reported rate of new cervical cancer cases
Israel
5.05 per 100,000 women
in 2017
Türkiye
5.13 per 100,000 women
in 2017
Israel rank
39th
Türkiye rank
38th
Reported rate of new cervical cancer cases over time
- Israel
- Türkiye
How they compare
Türkiye currently reports 5.13 per 100,000 women against 5.05 per 100,000 women in Israel, a difference of 0.08 per 100,000 women.
The two have swapped places 9 times across 20 shared years of data; in 1998 it was Israel ahead.
Israel ranks 39th and Türkiye ranks 38th of 46 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 5.59 per 100,000 women | 5.03 per 100,000 women | 0.569 per 100,000 women | Israel |
| 2000s | 5.49 per 100,000 women | 5.28 per 100,000 women | 0.2161 per 100,000 women | Israel |
| 2010s | 5.38 per 100,000 women | 5.29 per 100,000 women | 0.0839 per 100,000 women | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Israel or Türkiye?
- Türkiye, at 5.13 per 100,000 women against 5.05 per 100,000 women in Israel as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Israel and Türkiye?
- 0.08 per 100,000 women, with Türkiye ahead.
- How many years of comparable data are there for Israel and Türkiye?
- 20 years are reported by both, from 1998 to 2017.
- How do Israel and Türkiye rank globally for reported rate of new cervical cancer cases?
- Israel ranks 39th and Türkiye ranks 38th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.